The maintenance of energy equilibrium and cellular activities depends heavily on metabolic pathways. Numerous illnesses, including diabetes, cancer, and neurodegenerative diseases, can result from the dysregulation of these pathways. Promising treatment approaches are provided by molecular therapies that target these pathways.
In order to modify their activity for therapeutic purposes, recent research has concentrated on identifying important enzymes and receptors within metabolic networks. Small compounds, RNA-based treatments, and gene-editing methods like CRISPR-Cas9 are some of these approaches that may be able to address metabolic abnormalities. In cancer treatment, for example, controlling cell growth and metabolism through manipulation of the mTOR pathway has shown promise. Similarly, one of the main goals of diabetes treatment has been to target insulin signaling pathways.
Research in metabolic control and molecular biology is accelerating at Poddar International College. For both academics and practical exposure, the college's efforts to investigate the molecular causes of metabolic disorders present fascinating prospects. Poddar International College wants to add to the expanding corpus of knowledge in molecular therapies by offering novel treatments for metabolic diseases through the use of state-of-the-art instruments and interdisciplinary methodologies.
By comprehending and focusing on these pathways, treatment methods may be revolutionized and tailored medical strategies can be developed in addition to helping with disease management